The controversial approach, which has recently been making headlines in consumer media outlets, proposes that... ]]> feeds@yuku.com (squiffy2) http://msrcsharing.yuku.com/topic/15953 Mon, 07 Dec 2009 15:25:25 GMT http://msrcsharing.yuku.com/topic/15949/t/-Novartis----launch-Multiple-Sclerosis-oral-therapy-.html Novartis AG is jockeying with German drug maker Merck KgaA to deliver the first disease modifying treatment for relapsing forms of multiple sclerosis that can be taken orally, rather than by infusion or injection.

feeds@yuku.com (squiffy2) http://msrcsharing.yuku.com/topic/15949 Mon, 07 Dec 2009 08:28:58 GMT http://msrcsharing.yuku.com/topic/15942/t/Schoolboy-Ryan-McLaughlin-wins-Multiple-Sclerosis-vitamin-D-.html Pregnant women in Scotland are to be educated about the importance of taking vitamin D supplements thanks to a campaign by a 14-year-old Glasgow schoolboy.

Ryan McLaughlin, whose mother Kirsten has Multiple Sclerosis, took his case to the Scottish Parliament's petitions committee earlier this year.

He believes taking vitamin D can help prevent the... ]]> feeds@yuku.com (squiffy2) http://msrcsharing.yuku.com/topic/15942 Sat, 05 Dec 2009 11:54:53 GMT http://msrcsharing.yuku.com/topic/15941/t/UK-MS-Society-medical-advisors-unconvinced--Zamboni-s-CCSVI-.html Medical advisors to the UK MS Society have raised doubts about a theory put forward by Italian doctor Paulo Zamboni, who this week proposed that a vein disorder is the cause of multiple sclerosis (MS).

In a statement, the experts have found fault with the theory that MS is caused by blockages in veins that drain the brain and suggest that people with MS are unlikely to... ]]> feeds@yuku.com (squiffy2) http://msrcsharing.yuku.com/topic/15941 Sat, 05 Dec 2009 11:17:58 GMT http://msrcsharing.yuku.com/topic/15933/t/US-approves-13-embryonic-stem-cell-lines-for-research.html US regulators have approved 13 new lines of human embryonic stem cells for use in scientific research.

They are the first batches of embryonic stem cells - the building blocks of the body - that have been made available to US researchers in almost a decade.

The move comes after President Barack Obama eased restrictions on federally funded embryonic... ]]> feeds@yuku.com (squiffy2) http://msrcsharing.yuku.com/topic/15933 Thu, 03 Dec 2009 16:02:10 GMT http://msrcsharing.yuku.com/topic/15923/t/New-source-discovered---generation--nerve-cells---brain.html
The research group of Professor Magdalena Gotz of Helmholtz Zentrum Munchen and Ludwig-Maximilians-Universitat (LMU) Munich has made a significant advance in understanding regeneration processes in the brain. The researchers discovered progenitor cells which can form new glutamatergic neurons following injury to the cerebral cortex.... ]]> feeds@yuku.com (squiffy2) http://msrcsharing.yuku.com/topic/15923 Thu, 03 Dec 2009 09:34:47 GMT http://msrcsharing.yuku.com/topic/15922/t/Cannabis-shows-promise--reducing-multiple-sclerosis-patients.html Doses of cannabis might help multiple sclerosis (MS) patients subdue their body spasms and move about more easily, according to a new review of recent studies. However, the authors of the paper note,... ]]> feeds@yuku.com (squiffy2) http://msrcsharing.yuku.com/topic/15922 Thu, 03 Dec 2009 07:23:41 GMT http://msrcsharing.yuku.com/topic/15918/t/Glial-cells--cross---central---peripheral-nervous-.html Glial cells, which help neurons communicate with each other, can leave the central nervous system and cross into the peripheral nervous system to compensate for missing cells, according to new research in the Dec. 2 issue of The Journal of Neuroscience. The animal study contributes to researchers' basic understanding of how the two nervous systems develop and are... ]]> feeds@yuku.com (squiffy2) http://msrcsharing.yuku.com/topic/15918 Wed, 02 Dec 2009 13:44:52 GMT http://msrcsharing.yuku.com/topic/15917/t/Multiple-sclerosis-risk-sharing-scheme-two-year-results--cli.html
Objective To generate evidence on the longer term cost effectiveness of disease modifying treatments in patients with http://msrcsharing.yuku.com/topic/15917 Wed, 02 Dec 2009 11:43:10 GMT http://msrcsharing.yuku.com/topic/15916/t/Long-awaited-results--pilot-CCSVI--Multiple-Sclerosis-trial-.html A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency

Objective
Chronic cerebrospinal venous... ]]> feeds@yuku.com (squiffy2) http://msrcsharing.yuku.com/topic/15916 Wed, 02 Dec 2009 09:59:26 GMT http://msrcsharing.yuku.com/topic/15913/t/Betaferon-approved--China--treatment--Multiple-Sclerosis.html Bayer Schering Pharma AG announced that the Chinese State Food and Drug Administration (SFDA) has approved Betaferon® (interferon beta-1b) therapy for patients with feeds@yuku.com (squiffy2) http://msrcsharing.yuku.com/topic/15913 Tue, 01 Dec 2009 13:41:10 GMT http://msrcsharing.yuku.com/topic/15910/t/New-tool-in-fight-against-autoimmune-diseases-blood-cancers.html A study led by a Scripps Research Institute scientist describes a new, highly pragmatic approach to the identification of molecules that prevent a specific type of immune cells from attacking their host. The findings add a powerful new tool to the ongoing search for potential treatments for autoimmune diseases, such as multiple sclerosis (MS), as well as blood cancers, such as... ]]> feeds@yuku.com (squiffy2) http://msrcsharing.yuku.com/topic/15910 Tue, 01 Dec 2009 07:02:10 GMT http://msrcsharing.yuku.com/topic/15909/t/FDA-rejects-Multiple-Sclerosis-drug-Cladribine-application--.html U.S. regulators rejected as incomplete Merck KGaA's application to sell the oral treatment multiple sclerosis.